Template:CMV retinitis treatment: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
(Strip translate tags to enable SMW subobject creation) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
====Severe Vision Threatening==== | ====Severe Vision Threatening==== *Ganciclovir intraocular implant for 8 months AND | ||
*Ganciclovir intraocular implant for 8 months AND | **{{AntibioticDose|disease=CMV retinitis|drug=Valganciclovir|dose=900mg PO q12hrs x 14 days then 900mg PO q24hrs x 7 days|context=Severe vision threatening with intraocular implant|population=Adult}} | ||
**Valganciclovir 900mg PO q12hrs x 14 days | |||
====Peripheral lesions==== | |||
*Valganciclovir 900mg PO q12hrs x 21 days | ====Peripheral lesions==== *{{AntibioticDose|disease=CMV retinitis|drug=Valganciclovir|dose=900mg PO q12hrs x 21 days then 900mg PO q24hrs x 7 days|context=Peripheral lesions|population=Adult}} | ||
Latest revision as of 02:54, 20 March 2026
====Severe Vision Threatening==== *Ganciclovir intraocular implant for 8 months AND
- Valganciclovir 900mg PO q12hrs x 14 days then 900mg PO q24hrs x 7 days
====Peripheral lesions==== *Valganciclovir 900mg PO q12hrs x 21 days then 900mg PO q24hrs x 7 days